Witnessing the stock’s movement on the chart, on Wednesday, Geron Corp (NASDAQ: GERN) set off with pace as it heaved 10.62% to $1.77, before settling in for the price of $1.60 at the close. Taking a more long-term approach, GERN posted a 52-week range of $1.46-$5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 6535.01%. Meanwhile, its Annual Earning per share during the time was 5.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 61.35%. This publicly-traded company’s shares outstanding now amounts to $606.39 million, simultaneously with a float of $597.72 million. The organization now has a market capitalization sitting at $1.13 billion. At the time of writing, stock’s 50-day Moving Average stood at $2.6862, while the 200-day Moving Average is $3.8855.
Geron Corp (GERN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Geron Corp’s current insider ownership accounts for 6.15%, in contrast to 71.82% institutional ownership. According to the most recent insider trade that took place on Feb 27 ’25, this organization’s EVP, Chief Legal Officer bought 15,000 shares at the rate of 1.61, making the entire transaction reach 24,150 in total value, affecting insider ownership by 26,682. Preceding that transaction, on Feb 27 ’25, Company’s Chairman, President and CEO bought 12,500 for 1.76, making the whole transaction’s value amount to 22,062. This particular insider is now the holder of 12,500 in total.
Geron Corp (GERN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
Geron Corp’s EPS increase for this current 12-month fiscal period is 61.35% and is forecasted to reach 0.02 in the upcoming year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Let’s observe the current performance indicators for Geron Corp (GERN). It’s Quick Ratio in the last reported quarter now stands at 5.12. The Stock has managed to achieve an average true range (ATR) of 0.17. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.64.
In the same vein, GERN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.27, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be 0.02 at the market close of one year from today.
Technical Analysis of Geron Corp (GERN)
Going through the that latest performance of [Geron Corp, GERN]. Its last 5-days volume of 16.72 million indicated improvement to the volume of 15.25 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 33.66% While, its Average True Range was 0.1704.
Raw Stochastic average of Geron Corp (GERN) in the period of the previous 100 days is set at 10.19%, which indicates a major fall in contrast to 25.83% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 173.06% that was higher than 76.37% volatility it exhibited in the past 100-days period.
